Professor Oleg Nadashkevich is an internationally recognized rheumatologist, dermatologist, academic physician, clinical researcher, and medical educator with more than 40 years of professional experience in rheumatology, internal medicine, and dermatology. He currently serves as Professor of Medicine and Chief of the Department of Internal Medicine at Danylo Halytsky Lviv National Medical University, Lviv, Ukraine. He is also the Founder and Owner of the Academic Medical Group, a private multidisciplinary medical center in Lviv, where he practices as a rheumatologist and dermatologist.

Professor Nadashkevich has extensive expertise in systemic sclerosis, systemic lupus erythematosus, psoriatic arthritis and psoriasis, axial spondyloarthritis, rheumatoid arthritis, vasculitis, gout and gouty arthritis, polymyalgia rheumatica, fibromyalgia, autoimmune liver diseases, osteoarthritis, and inflammatory bowel diseases. He has participated in 38 clinical trials covering these major rheumatologic and autoimmune conditions.

His international academic experience includes fellowships in Rheumatology and Immunology at the University of Vienna/Allgemeines Krankenhaus, Austria, and several prestigious fellowships and research positions at the University of Alberta and University of Calgary, Canada. His research collaborations include GRAPPA, EUSTAR, SCTC, ASAS, and EASI, reflecting his active engagement with international rheumatology and autoimmune disease research. Through his clinical, academic, and research contributions, Professor Nadashkevich continues to advance knowledge and education in rheumatology and multidisciplinary medicine.

Kenneth R. Pelletier, PhD, MD, is a Clinical Professor of Medicine, Family and d Community Medicine, and Psychiatry at the University of California School of Medicine, San Francisco (UCSF). Dr. Pelletier is also Chairman of the American Health Association and is a Vice President with American Specialty Health. Prior to these positions, Dr. Pelletier served as Clinical Professor of Medicine at Stanford University School of Medicine; was Director of the Stanford Corporate Health Program (SCHP); and was Director of the NIH funded Complementary and Alternative Medicine Program at Stanford (CAMPS). From 1974 until joining the Stanford University School of Medicine in 1990, Dr. Pelletier held a dual appointment as an Associate Clinical Professor in the Department of Medicine and the Department of Psychiatry, University of California School of Medicine in San Francisco (UCSF). At the present time, Dr. Pelletier as a peer reviewer for the Journal of the American Medical Association (JAMA), the Journal of Occupational and Environmental Medicine(JOEM), and Annals of Internal Medicine. He is he author of 15 books including his newest book Change Your Genes – Change Your Life(2024).

Dr. Joan D’souza is a seasoned pharmacovigilance, clinical safety, and regulatory affairs leader with
progressive global experience across the US and Europe in clinical development (Phase I–IV) and
post-marketing safety, supporting biotech and pharmaceutical companies.
She currently serves as a Qualified Person for Pharmacovigilance (QPPV) and Regulatory Affairs
(LCPRA) in Switzerland, Germany, Austria, and Liechtenstein, and as a GVP/GCP auditor, as well as
Deputy local contact person for pharmacovigilance in the UK and Ireland liaising with regulatory
authorities including EMA, FDA, Swissmedic, BfArM, and MHRA. In these roles, she oversees
comprehensive safety surveillance and regulatory compliance across the entire product lifecycle,
from market release decision to regulatory submission.
With a rare combination of qualifications—a medical degree, licensure as a U.S. attorney, a Master’s
degree in Pharmacovigilance and Pharmacoepidemiology, and an ongoing PhD in Drug–Device
Combination Surveillance—Dr. D’souza brings a uniquely multidisciplinary perspective to drug safety
and combination products. She manages end-to-end case processing, medical review, signal
evaluation, aggregate report (DSUR, RMP, PSUR, PBRER, REMS), risk management planning, SOP
development, PSMF oversight, safety report submissions, regulatory authority liaison, and inspection
readiness.
Additionally, her leadership spans oversight of international safety teams, training curriculum
development, and strategic input on safety planning, ensuring clinical oversight and compliance
across product development through all phases of clinical trials and post-marketing activities.
As the founder of JD Pharma Services, a one-stop solution provider for pharmaceutical needs, a
Visiting lecturer for AH Akademie fur Fortbildung Heidelberg, a moderator of the Pharmacovigilance,
Regulatory Affairs, and Drug-Device Combination Working Groups at Zug Pharma Group
(Switzerland), as well as former President of the International Society of Pharmacovigilance Swiss
and Austria Chapter, Dr. D’souza remains a driving force in pharmacovigilance, regulatory oversight,
vendor management, and regulatory submissions. Fluent in English and German, she is dedicated to
advancing patient safety through operational and benefit–risk excellence and regulatory integrity.
Dr. D’souza’s therapeutic experience includes oncology, immunology, cardiology, gastroenterology,
rare diseases, endocrinology, dermatology, and neurology, among others. She remains deeply
committed to advancing patient safety and regulatory excellence in complex global environments.
Dr. Joan D’Souza
CEO
JD Pharma Services
Bridging medical, regulatory, and legal expertise to strengthen global pharmacovigilance compliance.

Professor Dr Aisha M Elbareg, MBBS. DGO, DUOG, Dip.UG, FCRG, MMedSci, (ART),
ABOG, MD, PhD. Senior Consultant Obstetrician & Gynecologist with Sub-Specialty in
Reproductive Medicine. Staff member, Faculty of Medicine, Misrata University, Head
dept., Al-Jazeera International Hospital, Misrata. First Female from Sirt who graduated
as a doctor and obtained her medical degree (MBBS) in 1994 from Benghazi, (AL-Arab
Medical University). Previous Head dept Obstetrics & Gynecology both at the Faculty of
Medicine, Sirt University and Iben Sina Teaching Hospital, (2009-2012). Became Full
Professor in May-2021. Head Dept, Faculty of Medicine, & Postgraduate Coordinator,
Misrata University (2022-2024). Lecturer for postgraduate students doing Master degree
in Medical Genetics, Libyan Academy, Misrata Branch. Examiner for students doing PhD
in IVF, Misrata University. Ex-Examiner for postgraduate doctors doing ABOG. In (2001)
awarded a Master degree of Medical Sciences in Assisted Reproductive Techniques
(ART), from Nottingham University, UK and a PhD from the University of Manchester, UK
in (2007), in addition to the Specialization degree in Obstetrics & Gynecology:{Arab
Board of Obstetrics & Gynecology/ ABOG, in (2005)}, and several other diplomas
including: Diploma in Urogynecology & Pelvic Floor Reconstruction, Professional
Diploma in obstetrics & Gynecology Ultrasound, Professional Diploma & Fellowship in
Aesthetic Gynecology. Attended several advanced Courses: in {(IVF/ICSI), Leuven
University Fertility Centre, Belgium for twelve weeks}, {Prolapse Surgery and Non
Descent Vaginal Hysterectomy, Nepalgunj University/Nepal for four weeks}, {Several
sessions of Gynecological Endoscopic Surgery, Alexandria-Egypt}, Ultrasound courses in
Turkey and those organized by {Egyptian Society of Maternal & Fetal Medicine}, Courses
organized by International Society of Aesthetic Genital Surgery and Sexology. Published
41 papers, and attended more than 475 Scientific Meetings, Seminars, Workshops,
national and International Congresses since graduation, being a Speaker among most of
them, also being as an editorial board member, reviewer, and member: of the Scientific
Committees of several Local & International Journals and Conferences such as {44th
,45th, 46th & 47th}: (2015), (2016), (2017), (2018)), and the 50th (2021) AAGL Minimally
Invasive Gynecology Global Congress, U.S.A, also reviewer for the scientific abstracts
submitted to the (RCOG World Congress, 2023, 2024 & 2025), in addition to the
membership of Professional Societies in field of Specialization. Research Interest:
Reproductive Medicine, Aesthetic Gynecology /Gyn. Endoscopic Surgery.

Prof. Dr. Mohammad Kamil is a distinguished scientist, academician, and global expert in medicinal plants, natural products, phytopharmaceutical chemistry, traditional medicine, and plant sciences. He currently serves as Director General of Lotus Holistic Healthcare Institute, Abu Dhabi, UAE, and is the Secretary General and Head of the Scientific Committee for the Sheikh Zayed International TCAM Awards. He earned his Ph.D. from Aligarh Muslim University, India, completed postdoctoral research in the UK, and was awarded the prestigious Doctor of Science (D.Sc.) degree. He is also a Chartered Chemist (CChem) and Fellow of the Royal Society of Chemistry (FRSC), UK.

Prof. Kamil has made outstanding contributions to herbal medicine research, having standardized over 1,000 herbal and phytopharmaceutical products and discovered several novel natural compounds. His scholarly achievements include 850+ publications, seven books, six book chapters, and supervision of 35 Ph.D. scholars. He has received numerous international honors, including the Sheikh Zayed International TCAM Award and the UAE Golden Visa for exceptional talent. He actively collaborates with the World Health Organization (WHO) and serves on the editorial and organizing committees of several international journals and scientific conferences.

Thomas J. Webster’s (H index: 139) degrees are in chemical engineering from the University of Pittsburgh (B.S., 1995; USA) and in biomedical engineering from RPI (Ph.D., 2000; USA). He has formed over a dozen companies who have numerous FDA approved medical products currently improving human health in over 45,000 patients. He is currently helping those companies and serves as a professor at Brown University, Saveetha University, Hebei University of Technology, UFPI, University of the Basque Country, and others. Dr. Webster has numerous awards including: 2020, World Top 2% Scientist by Citations (PLOS); 2020, SCOPUS Highly Cited Research (Top 1% Materials Science and Mixed Fields); 2021, Clarivate Top 0.1% Most Influential Researchers (Pharmacology and Toxicology); 2022, Best Materials Science Scientist by Citations (Research.com); and is a fellow of over 8 societies. Prof. Webster is a former President of the U.S. Society for Biomaterials and has over 1,350 publications to his credit with over 55,000 citations. He was recently nominated for the Nobel Prize in Chemistry. Prof. Webster also recently formed a fund to support Nigerian student research opportunities in the U.S.

Associate Professor Dr. Tuan Salwani Tuan Ismail is a Consultant Chemical Pathologist and Head of
the Department of Chemical Pathology at the School of Medical Sciences, Universiti Sains Malaysia
(USM). She also serves as the Director of the Endocrine Laboratory at Hospital Universiti Sains
Malaysia, where she leads clinical diagnostic and research activities in endocrine laboratory medicine.
She obtained her Bachelor of Medicine and Bachelor of Surgery (MBBS) from the University of Malaya
and subsequently completed her Master of Pathology (Chemical Pathology) at Universiti Sains
Malaysia. Her areas of expertise include reproductive endocrinology, diabetes, vitamin D metabolism,
thyroid and parathyroid disorders, and laboratory biomarkers.
Dr. Tuan Salwani has published more than 40 peer-reviewed articles in international journals and has
successfully secured several national and international research grants. Her current research focuses
on Anti-Müllerian Hormone (AMH) as a biomarker of ovarian reserve and reproductive health,
including the establishment of population-specific reference intervals and the evaluation of factors
influencing AMH concentrations. She is also actively involved in translational research on endocrine
biomarkers, metabolomics in diabetes, and the development of novel DNA aptamer-based
technologies for hormone assays.
In addition to her research activities, she contributes to postgraduate education, specialist training,
and scientific peer review for international journals. Through her work, she aims to advance laboratory
diagnostics and translational endocrine research to support evidence-based clinical practice and
improve patient outcomes.

Cristina Iwabe is a distinguished physiotherapist and researcher specializing in pediatric neurology and neuromuscular rehabilitation. She graduated from the University of São Paulo (USP) and earned her specialization, Master's, and Ph.D. in Medical Sciences from Unicamp, where she also completed a postdoctoral fellowship in Neurology and Neuromuscular Disorders. As a collaborating researcher at Unicamp's Neuromuscular Diseases Division, she focuses on rehabilitation strategies for neuromuscular disorders. Dr. Iwabe is the official instructor for the Motor Function Measure (MFM) Scale in Brazil and has extensive expertise in the assessment and rehabilitation of patients with spinal muscular atrophy (SMA) and muscular dystrophies.

Professor Seyda Efsun Ozgunay, MD, graduated from the Faculty of Medicine at Ankara University and completed her residency training in the Department of Anesthesiology and Reanimation at Ankara University Faculty of Medicine.

She currently serves as a faculty member in the Department of Anesthesiology and Reanimation at the Faculty of Medicine, University of Health Sciences Türkiye, Bursa Yüksek İhtisas Training and Research Hospital. She holds certifications in both acupuncture and medical hypnosis and is an accredited hypnosis instructor certified by the Turkish Ministry of Health. Throughout her academic career, she has served on the scientific, organizing, and advisory committees of numerous national and international congresses in the fields of anesthesiology and traditional and complementary medicine. She has delivered invited lectures and scientific presentations at many academic conferences and professional meetings. In addition, she has served as a member of a Clinical Research Ethics Committee.

Professor Özgünay has authored numerous national and international scientific publications and book chapters, particularly focusing on the application of hypnosis in the operating room and intensive care unit. Her publications have been cited in multiple systematic reviews and meta-analyses. Her research in Traditional and Complementary Medicine (GETAT) primarily investigates the role of hypnosis in perioperative and critically ill patients. Her principal research interests include the effects of hypnosis on pain management, sedation, anxiety reduction, and prehabilitation. She is currently conducting research on the adjunctive role of hypnosis in anesthesia and intensive care, with particular emphasis on reducing perioperative adverse effects. Another major area of her research focuses on the application and effects of hypnosis during pregnancy and infancy.

Professor Özgünay participated in the National Tobacco Control Workshop organized by the General Directorate of Public Health of the Turkish Ministry of Health. She continues to conduct research on tobacco dependence and smoking cessation. She is also a member of the Scientific Board for Clinical Research and Projects at the Institute of Traditional and Complementary Medicine (TÜGET), under the Health Institutes of Türkiye (TÜSEB).

She is an active member of several professional organizations, including the Ankara Acupuncture and Complementary Medicine Association, the Medical Hypnosis Association, the Ankara Medical Hypnosis Association, and the İzmir Traditional and Complementary Medicine (GETAT) Association.

Serend Hipe obtained a doctorate in Medicine in 1992. She became a teacher in universities
(France) then became an Associate Professor in Paris and Montreal. Since retiring, she has
created the IFPEA (Paris, Montreal, Topeka) where different research sectors are developed
with the constant aim of energizing the sciences through an innovative epistemological
approach. She has published in prestigious journals (for example : Neuropsychiatry 2026,
SunText Review of Pediatric Care 2026, Journal of Medical Case Studies 2025, Journal of
Clinical & Biomedical Research 2025, The Scientist, 2024, ) and her work is recognized by the
international community.

A practicing physician in the field of healthcare in the state of Kerala in India for the last 38 years and very much interested in basic research. My interest is spread across the fever, inflammation and back pain. I am a writer. I already printed and published Ten books on these subjects. I wrote hundreds of articles in various magazines. My 15 articles published in various journals.

Dr. Ghamdan Alsadeh is a Consultant Intensivist and Head of Department (HOD) of the Intensive Care Unit at Ibrahim Bin Hamad Obaidullah Hospital, Ras Al Khaimah, United Arab Emirates. He has extensive experience in intensive care medicine, including advanced critical care management, emergency procedures, and multidisciplinary ICU leadership. He has strong expertise in complex clinical decision-making, invasive procedures, and ICU service development. He has contributed to multiple peer-reviewed publications and case reports across various medical specialties, reflecting a strong commitment to evidence-based medicine, academic research, and medical education being a faculty member of the Emirates Health Services Critical Care Fellowship Program.